Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective

被引：23

作者：

Todesco, Eve ^{[1
,2
]}

Mazzola, Alessandra ^{[3
]}

Akhavan, Sepideh ^{[2
,4
]}

Abravanel, Florence ^{[5
,6
]}

Poynard, Thierry ^{[7
,8
,9
]}

Roque-Afonso, Anne-Marie ^{[10
]}

Peytavin, Gilles ^{[11
,12
]}

Marcelin, Anne-Genevieve ^{[1
,2
]}

Calmus, Yvon ^{[3
]}

Lecuyer, Lucien ^{[13
]}

Guillemain, Romain ^{[14
]}

Conti, Filomena ^{[3
]}

机构：

[1] UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP,UMRS 1136, Paris, France

[2] Hop La Pitie Salpetriere, AP HP, Dept Virol, Paris, France

[3] UPMC Paris VI, Hop Pitie Salpetriere, AP HP, Unite Med Transplantat Hepat,Hepatogastroenterol, Blvd Hop, Paris, France

[4] UPMC Univ Paris 06, Sorbonne Univ, CIMI Paris UMRS CR7, PVI Team,Inserm,U1135, Paris, France

[5] CHU Toulouse, Hop Purpan, Lab Virol, Natl Reference Ctr Hepatitis E, Toulouse, France

[6] INSERM, Ctr Physiopathol Toulouse Purpan, U1043, Toulouse, France

[7] Grp Hosp Pitie Salpetriere, AP HP, Paris, France

[8] UPMC Univ Paris 06, Sorbonne Univ, UMR S 938, Paris, France

[9] INSERM, Inst Cardiometab & Nutr ICAN, Paris, France

[10] Univ Paris Sud, Hop Paul Brousse, AP HP, INSERM,Virol,U1193, Villejuif, France

[11] Bichat Claude Bernard Hosp, AP HP, Pharmacotoxicol Dept, Paris, France

[12] Univ Paris Diderot, Sorbonne Paris Cite, IAME, INSERM,UMR 1137, Paris, France

[13] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Cardiovasc, Paris, France

[14] Hop Europeen Georges Pompidou, AP HP, Pole Cardiovasc Nephrol Hypertens Diabet, Unite Fonct Transplantat Thorac, Paris, France

来源：

ANTIVIRAL THERAPY | 2018年 / 23卷 / 05期

关键词：

E VIRAL-INFECTION; REPLICATION;

D O I：

10.3851/IMP3227

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Hepatitis E virus (HEV) can induce chronic infections in the case of immunosuppression, which are sometimes not cured with ribavirin. Furthermore, sofosbuvir is a highly potent inhibitor of HCV polymerase and was shown to inhibit HEV genotype-3 replication in vitro. We report here the outcome of sofosbuvir/ribavirin therapy on a chronic HEV infection in a heart transplant recipient non-responder to ribavirin. After 24 weeks, the regimen failed to cure the persistent HEV infection, highlighting the need of therapeutic options for HEV-infected immunosuppressed patients.

引用

页码：463 / 465

页数：3

共 50 条

[1] The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy
Sastre, Lydia
Garcia-Lopez, Mireia
Perez-del-Pulgar, Sofia
Lens, Sabela
Costa, Josep
Navasa, Miguel
Forns, Xavier
GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (03): : 136 - 137
[2] Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin
Todesco, Eve
Demeret, Sophie
Calin, Ruxandra
Roque-Afonso, Anne-Marie
Thibault, Vincent
Mallet, Vincent
Akhavan, Sepideh
Jaspard, Marie
Peytavin, Gilles
Poynard, Thierry
Katlama, Christine
Pourcher, Valerie
AIDS, 2017, 31 (09) : 1346 - 1348
[3] Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
Fraga, Montserrat
Gouttenoire, Jerome
Sahli, Roland
Chtioui, Haithem
Marcu, Cristina
Pascual, Manuel
Moradpour, Darius
Vionnet, Julien
BMC GASTROENTEROLOGY, 2019, 19 (1)
[4] Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
Montserrat Fraga
Jérôme Gouttenoire
Roland Sahli
Haithem Chtioui
Cristina Marcu
Manuel Pascual
Darius Moradpour
Julien Vionnet
BMC Gastroenterology, 19
[5] Sofosbuvir and Ribavirin Eradication of Refractory Hepatitis E in an Immunosuppressed Kidney Transplant Recipient
Drinane, Mary
Wang, Xiao Jing
Watt, Kymberly
HEPATOLOGY, 2019, 69 (05) : 2297 - 2299
[6] Combination therapy of sofosbuvir and ribavirin fails to clear chronic hepatitis E infection in a multivisceral transplanted patient
Schulz, Marten
Papp, C. Patrick
Bock, Claus-Thomas
Hofmann, Joerg
Gerlach, Undine A.
Maurer, Max Magnus
Eurich, Dennis
Mueller, Tobias
JOURNAL OF HEPATOLOGY, 2019, 71 (01) : 225 - 227
[7] Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy
Carmo, Joana
Marques, Susana
Mateus, Elia
Morbey, Ana
Veloso, Julio
Almeida-Santos, Madalena
Curran, Martin
Barroso, Eduardo
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (07) : 608 - 608
[8] Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Ribavirin-Containing Regimens: Sofosbuvir/Velpatasvir and Ribavirin or Sofosbuvir and Ribavirin
Younossi, Zobair M.
Stepanova, Maria
Feld, Jordan
Zeuzem, Stefan
Sulkowski, Mark
Foster, Graham R.
Mangia, Alessandra
Charlton, Michael R.
O'Leary, Jacqueline G.
Curry, Michael
Nader, Fatema
Hunt, Sharon
GASTROENTEROLOGY, 2016, 150 (04) : S1046 - S1046
[9] Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
Kamar, Nassim
Izopet, Jacques
Tripon, Simona
Bismuth, Michael
Hillaire, Sophie
Dumortier, Jerome
Radenne, Sylvie
Coilly, Audrey
Garrigue, Valerie
D'Alteroche, Louis
Buchler, Matthias
Couzi, Lionel
Lebray, Pascal
Dharancy, Sebastien
Minello, Anne
Hourmant, Maryvonne
Roque-Afonso, Anne-Marie
Abravanel, Florence
Pol, Stanislas
Rostaing, Lionel
Mallet, Vincent
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (12): : 1111 - 1120
[10] Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin
Biliotti, Elisa
Franchi, Cristiana
Spaziante, Martina
Garbuglia, Anna Rosa
Volpicelli, Lorenzo
Palazzo, Donatella
De Angelis, Maurizio
Esvan, Rozenn
Taliani, Gloria
INFECTION, 2018, 46 (05) : 725 - 727

← 1 2 3 4 5 →